Table 3.

Examples of monitoring, management, and documentation of most common AKI complications.

Recognition	Action Monitoring	Risk reduction	Management	Results Result
Hyperkalemia (K>6)	• Serial Monitoring (Daily while in AKI)	• Discontinuation of potentiating therapies (K replacement, K-sparing diuretics, K affecting drugs)	• Time to intervention, effectiveness, follow-up	• Frequency of severe hyperkalemia, dialysis, death from hyperkalemia
Avoidable Severe Adverse Drug Event (e.g. renal-eliminated opiates)	• Detection of no-go meds, complication monitoring	• Stop ‘no-go’ meds (e.g., morphine, meperidine) • Use of alternative analgesics, dose adjustment (challenging), augmented monitoring for ADEs	• Time to intervention, effectiveness, follow-up	• Avoidable ADE (e.g., respiratory depression, sedation, death), • Improved Therapeutic Drug Monitoring
Volume Overload > 10% of admission body weight	• strict I/O, daily weights	• Daily Assessment, voidance of ‘maintenance IV fluid’	• Time to intervene	• Measure % volume overload in EHR flowsheet